Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Eagle Pharmaceuticals Inc. logo

Eagle Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

Optionable: Yes  Market Cap: 107 M  90-day average vol: 138,640

Previous close: 5.85  Open: 5.78  Bid: 5.89  Ask: 6.35
52 week range    
JNJ / 
GSK / 
NVS / 
LLY / 
Last updated: Sunday 3rd December 2023
MarketXLS Rank

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord



StockDividendMarket Cap (B)PEPrice ($)


0.0347129 B23.4223.53


0.0332145 B-27.366.19



0.0247450 B22.1171.06


0.0161238 B37.4243.55




EGRX Income Statement

Invalid dateSep-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends-2 M
Amortization-948000.0-3 M-3 M3 M3 M40 M-11 M
Amortization of intangibles-948000.0-3 M-3 M3 M3 M40 M-11 M
Basic EPS from continuing operations1.040.89-0.66
Basic EPS total-1.970.175.243.442.161.040.89-0.662.76
Basic weighted shares outstanding10 M15 M16 M15 M15 M14 M13 M13 M13 M
Cost of sales-5 M-8 M-36 M-34 M-42 M48 M34 M32 M-85 M
Depreciation-104000.0-112000.0-641000.0-932000.0-1 M972000.0872000.0764000.0-646000.0
DepreciationAndAmortization-104000.0-112000.0-641000.0-932000.0-1 M972000.0872000.0764000.0-646000.0
Diluted EPS total-1.970.164.963.
Diluted normalized net income/share1.010.87-0.66
Diluted weighted shares outstanding10 M16 M16 M16 M15 M14 M14 M13 M13 M
GainOnSaleOfPPE2 M
GainOnSaleOfSecurity-5 M-6 M-4 M
GeneralAndAdministrativeExpense2 M-514000.0-1000.0-664000.0-571000.076 M79 M75 M-2 M
Gross operating profit7 M58 M154 M203 M171 M148 M154 M140 M231 M
ImpairmentOfCapitalAssets7 M3 M
Income before tax-19 M3 M53 M73 M34 M22 M23 M-5 M61 M
Income restructuring and M&A2 M8 M
Income taxes-1 M3000.0-28 M21 M2 M8 M11 M4 M26 M
Interest income31000.025000.084000.091000.0158000.02 M562000.0560000.0271000.0
InterestExpenseNonOperating8000.011000.08000.01 M3 M3 M3 M2 M4 M
MarketingExpense-3 M-5 M-15 M-18 M-3 M2 M3 M3 M-8 M
MiscOtherSpecialCharges-538000.0-300000.0700000.0-8 M-6 M-16 M
Net income from total operations-20 M3 M81 M52 M32 M14 M12 M-9 M36 M
NetIncomeCommonStockholders-20 M3 M81 M52 M32 M14 M12 M-9 M36 M
NetIncomeContinuousOperations-20 M3 M81 M52 M32 M14 M12 M-9 M36 M
NetNonOperatingInterestIncomeExpense23000.014000.076000.0-1 M-3 M-517000.0-2 M-1 M-4 M
NonRecurringOperationExpense2 M
Normalized income-4 M
Operating income-20 M3 M53 M75 M46 M22 M33 M3 M81 M
Operating income before depreciation (EBITDA)-19 M3 M55 M78 M41 M30 M30 M2 M79 M
OperatingExpense-38 M-64 M-136 M-163 M124 M126 M121 M137 M150 M
Other income net538000.0-793000.0-7 M-763000.0-700000.08 M6 M16 M
OtherGandA2 M-514000.0-1000.0-664000.0-571000.076 M79 M75 M-2 M
OtherOperatingExpenses-38 M8 M20 M23 M20 M13 M12 M11 M9 M
OtherunderPreferredStockDividend-2 M
PreferredStockDividends-2 M
Research & development expense17 M28 M28 M33 M44 M37 M31 M51 M34 M
ResearchExpense17 M28 M28 M33 M44 M37 M31 M51 M34 M
RestructringAndMnAIncome2 M8 M
SalariesAndWages-606000.0-4 M-10 M-15 M-19 M-16 M
Selling Gen & administrative expense11 M20 M53 M71 M61 M76 M79 M75 M107 M
SellingAndMarketingExpense9 M20 M53 M71 M61 M2 M3 M3 M107 M
SellingExpense9 M20 M53 M71 M61 M107 M
Special income/charges-2 M-9 M-11 M
Total Income available for interest expense (EBIT)-19 M3 M53 M74 M37 M25 M25 M-3 M65 M
Total common shares outstanding14 M16 M15 M15 M14 M14 M13 M13 M13 M
Total net income-20 M3 M81 M52 M32 M14 M12 M-9 M36 M
Total ordinary shares13 M13 M13 M13 M13 M13 M13 M13 M13 M
Total revenues19 M66 M189 M237 M213 M196 M188 M172 M317 M
TotalExpenses-43 M-71 M-172 M-196 M82 M174 M155 M169 M65 M
TotalRevenue5 M13 M41 M237 M213 M196 M188 M172 M317 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today